We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Perils with Pirfenidone and "the tuberculosis link".
- Authors
Hande, Madhav; Acharya, K; Shreenivasa, A; Nayak, Kashinath; Arun, S
- Abstract
We report a case of idiopathic pulmonary fibrosis (IPF) treated with pirfenidone who developed tuberculosis (TB) and later had exfoliative dermatitis secondary to an interaction between pirfenidone and rifampicin. This case report highlights the possible risk of developing TB in patients diagnosed with IPF and on antifibrotic therapy like pirfenidone. Furthermore, this case report documents a previously unreported adverse reaction due to the interaction of rifampicin with pirfenidone.
- Publication
International Journal of Mycobacteriology, 2019, Vol 8, Issue 3, p298
- ISSN
2212-5531
- Publication type
Article
- DOI
10.4103/ijmy.ijmy_96_19